BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17901649)

  • 1. The use of MTT [3-(4, 5-dimethyl-2-thiazolyl) -2, 5-diphenyl -2H- tetrazolium bromide]-reduction as an indicator of the effects of strain-specific, polyclonal rabbit antisera on Candida albicans and C. krusei.
    Arseculeratne SN; Atapattu DN; Kumarasiri R; Perera D; Ekanayake D; Rajapakse J
    Indian J Med Microbiol; 2007 Jul; 25(3):267-71. PubMed ID: 17901649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Candida krusei with human neutrophils in vitro.
    Richardson MD; Donaldson F
    J Med Microbiol; 1994 Dec; 41(6):384-8. PubMed ID: 7966213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulins G could prevent adherence of Candida albicans to polystyrene and extracellular matrix components.
    Rodier MH; Imbert C; Kauffmann-Lacroix C; Daniault G; Jacquemin JL
    J Med Microbiol; 2003 May; 52(Pt 5):373-377. PubMed ID: 12721311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement and antibody in opsonization and intracellular killing of Candida albicans.
    Pereira HA; Hosking CS
    Clin Exp Immunol; 1984 Aug; 57(2):307-14. PubMed ID: 6380832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment and evaluation of a double antibody sandwich ELISA to detect Csa2 protein of Candida albicans].
    Liu L; Cai J; Liu C; Guo Y; Pan Y; Wang Y; Che X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):732-5. PubMed ID: 25001939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel monoclonal antibody recognizing beta(1-3) glucans in intact cells of Candida and Cryptococcus.
    Kondori N; Edebo L; Mattsby-Baltzer I
    APMIS; 2008 Oct; 116(10):867-76. PubMed ID: 19132980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT) is dependent on CaFRE10 ferric reductase for Candida albicans grown in unbuffered media.
    Knight SAB; Dancis A
    Microbiology (Reading); 2006 Aug; 152(Pt 8):2301-2308. PubMed ID: 16849796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils.
    Arai T; Mikami Y; Yokoyama K
    Sabouraudia; 1977 Jul; 15(2):171-7. PubMed ID: 333623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and saliva antibodies do not inhibit Candida albicans Sap2 proteinase activity using a BSA hydrolysis assay.
    Naglik JR; Scott J; Rahman D; Mistry M; Challacombe SJ
    Med Mycol; 2005 Feb; 43(1):73-7. PubMed ID: 15712610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Candida sp. mannan antigen by indirect ELISA-inhibition. In vitro crossed reactivity among mannans obtained from C. albicans A, C. albicans B, and C. tropicalis.
    Garcia-de-Lomas J; Morales C; Grau MA; Mir A
    Mycopathologia; 1988 Jun; 102(3):175-8. PubMed ID: 3050526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crossreactivity at the immunoglobulin E level of the cell wall mannoproteins of Candida albicans with other pathogenic Candida and airborne yeast species.
    Kanbe T; Utsunomiya K; Ishiguro A
    Clin Exp Allergy; 1997 Dec; 27(12):1449-57. PubMed ID: 9433941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic relationships between Candida albicans and various yeasts as reflected by immunoglobulin-class specificity.
    Segal E; Vardinon N; Schwartz J; Eylan E
    Pathol Microbiol (Basel); 1975; 42(1):49-58. PubMed ID: 50586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
    Yang HC; Mikami Y; Yazawa K; Taguchi H; Nishimura K; Miyaji M; Branchini ML; Aoki FH; Yamamoto K
    Mycoses; 1998 Dec; 41(11-12):477-80. PubMed ID: 9919890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antibodies on the respiration and morphology of Candida Albicans.
    Grappel SF; Calderone RA
    Sabouraudia; 1976 Mar; 14(1):51-60. PubMed ID: 772840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of a monoclonal antibody against mannoprotein of Candida albicans.
    Farahnejad Z; Rasaee MJ; Moghadam MF; Paknejad M; Kashanian S; Rajabi M
    Hybridoma (Larchmt); 2005 Jun; 24(3):146-51. PubMed ID: 15943562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological relatedness among Candida albicans and other pathogenic Candida species.
    Hector RF; Lyon FL; Domer JE
    Infect Immun; 1981 Dec; 34(3):844-50. PubMed ID: 7037643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-biofilm activity of antibody directed against surface antigen complement receptor 3-related protein-comparison of Candida albicans and Candida dubliniensis.
    Chupácová J; Borghi E; Morace G; Los A; Bujdáková H
    Pathog Dis; 2018 Feb; 76(1):. PubMed ID: 29315379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological cross reactivity between Candida albicans and human tissue.
    Vojdani A; Rahimian P; Kalhor H; Mordechai E
    J Clin Lab Immunol; 1996; 48(1):1-15. PubMed ID: 10332630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections.
    Moragues MD; Omaetxebarria MJ; Elguezabal N; Bikandi J; Quindós G; Coleman DC; Pontón J
    J Clin Microbiol; 2001 Aug; 39(8):2999-3001. PubMed ID: 11474033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis of Candida albicans by eosinophilic leukocytes.
    Ishikawa T; Dalton AC; Arbesman CE
    J Allergy Clin Immunol; 1972 May; 49(5):311-5. PubMed ID: 4553436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.